Published in J Neurosci on June 01, 1999
Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science (2008) 9.24
A resource of Cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex. Neuron (2011) 6.93
The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev (2006) 6.80
Defined types of cortical interneurone structure space and spike timing in the hippocampus. J Physiol (2004) 5.57
Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A (2002) 5.33
The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron (2006) 4.12
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev (2008) 3.51
Cortical parvalbumin interneurons and cognitive dysfunction in schizophrenia. Trends Neurosci (2011) 3.17
Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci (2006) 2.81
Functional maps of neocortical local circuitry. Front Neurosci (2007) 2.79
Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells. Nat Neurosci (2006) 2.59
Regulation of neuronal input transformations by tunable dendritic inhibition. Nat Neurosci (2012) 2.28
Endocannabinoid signaling and synaptic function. Neuron (2012) 1.90
Supply and demand for endocannabinoids. Trends Neurosci (2011) 1.78
Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat Neurosci (2009) 1.77
Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proc Natl Acad Sci U S A (2009) 1.75
Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling. J Pharmacol Exp Ther (2009) 1.74
Activity-dependent regulation of synapses by retrograde messengers. Neuron (2009) 1.73
Sex Differences in Molecular Signaling at Inhibitory Synapses in the Hippocampus. J Neurosci (2015) 1.71
Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus. J Physiol (2006) 1.71
Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons. Proc Natl Acad Sci U S A (2004) 1.64
Hippocampal sharp wave-ripple: A cognitive biomarker for episodic memory and planning. Hippocampus (2015) 1.63
Asynchronous transmitter release from cholecystokinin-containing inhibitory interneurons is widespread and target-cell independent. J Neurosci (2009) 1.60
Multiple functions of endocannabinoid signaling in the brain. Annu Rev Neurosci (2012) 1.60
Distribution and posttranslational modification of synaptic ERα in the adult female rat hippocampus. Endocrinology (2012) 1.52
Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat Neurosci (2010) 1.48
Cannabinoid Control of Learning and Memory through HCN Channels. Neuron (2016) 1.46
Active endocannabinoids are secreted on extracellular membrane vesicles. EMBO Rep (2015) 1.45
Cannabis and psychosis/schizophrenia: human studies. Eur Arch Psychiatry Clin Neurosci (2009) 1.37
Membrane assembly of the cannabinoid receptor 1: impact of a long N-terminal tail. Mol Pharmacol (2003) 1.37
Estradiol acutely suppresses inhibition in the hippocampus through a sex-specific endocannabinoid and mGluR-dependent mechanism. Neuron (2012) 1.36
Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br J Pharmacol (2004) 1.35
Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proc Natl Acad Sci U S A (2005) 1.33
Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex. J Physiol (2011) 1.32
Network mechanisms of theta related neuronal activity in hippocampal CA1 pyramidal neurons. Nat Neurosci (2010) 1.32
Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice. J Neurosci (2011) 1.32
The maturation of GABAergic transmission in visual cortex requires endocannabinoid-mediated LTD of inhibitory inputs during a critical period. Neuron (2010) 1.32
Basket cell dichotomy in microcircuit function. J Physiol (2011) 1.30
Initial loss but later excess of GABAergic synapses with dentate granule cells in a rat model of temporal lobe epilepsy. J Comp Neurol (2010) 1.30
Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. Am J Psychiatry (2010) 1.30
Effects of endocannabinoid system modulation on cognitive and emotional behavior. Front Behav Neurosci (2011) 1.29
Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve. J Physiol (2004) 1.29
Release probability-dependent scaling of the postsynaptic responses at single hippocampal GABAergic synapses. J Neurosci (2006) 1.27
Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus. Eur J Neurosci (2005) 1.26
Quantitative assessment of CA1 local circuits: knowledge base for interneuron-pyramidal cell connectivity. Hippocampus (2013) 1.26
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome. J Neurosci (2010) 1.24
Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology (Berl) (2003) 1.24
Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation. Learn Mem (2007) 1.24
Complementary modulation of somatic inhibition by opioids and cannabinoids. J Neurosci (2008) 1.23
Targeting dopamine D2 and cannabinoid-1 (CB1) receptors in rat nucleus accumbens. J Comp Neurol (2006) 1.22
Altering cannabinoid signaling during development disrupts neuronal activity. Proc Natl Acad Sci U S A (2005) 1.21
New dimensions of interneuronal specialization unmasked by principal cell heterogeneity. Trends Neurosci (2011) 1.20
Pharmacological treatments that facilitate extinction of fear: relevance to psychotherapy. NeuroRx (2006) 1.20
Functional characteristics of parvalbumin- and cholecystokinin-expressing basket cells. J Physiol (2012) 1.19
Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. J Physiol (2004) 1.19
Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol. Neuropsychopharmacology (2009) 1.19
Signaling via CNS cannabinoid receptors. Mol Cell Endocrinol (2008) 1.18
Integration of electrophysiological recordings with single-cell RNA-seq data identifies neuronal subtypes. Nat Biotechnol (2015) 1.18
Gamma oscillation deficits and the onset and early progression of schizophrenia. Harv Rev Psychiatry (2010) 1.17
Origin, early commitment, migratory routes, and destination of cannabinoid type 1 receptor-containing interneurons. Cereb Cortex (2009) 1.17
Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nat Neurosci (2014) 1.14
Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus. Proc Natl Acad Sci U S A (2008) 1.13
Anti-inflammatory property of the cannabinoid agonist WIN-55212-2 in a rodent model of chronic brain inflammation. Neuroscience (2006) 1.13
The endocannabinoid system as a target for the treatment of neurodegenerative disease. Br J Pharmacol (2010) 1.11
Non-synaptic receptors and transporters involved in brain functions and targets of drug treatment. Br J Pharmacol (2010) 1.11
Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats. Neurobiol Aging (2007) 1.11
Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons. J Neurochem (2008) 1.11
Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex. Neuroscience (2010) 1.10
More surprises lying ahead. The endocannabinoids keep us guessing. Neuropharmacology (2013) 1.10
Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others. Neuropharmacology (2007) 1.10
Cannabinoid signaling in inhibitory autaptic hippocampal neurons. Neuroscience (2009) 1.10
Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia. Eur J Neurosci (2009) 1.09
Selective reduction of cholecystokinin-positive basket cell innervation in a model of temporal lobe epilepsy. J Neurosci (2010) 1.09
Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy. Neuroscience (2007) 1.09
Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia. Exp Brain Res (2006) 1.08
Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission. Eur J Neurosci (2007) 1.08
Expression of COUP-TFII nuclear receptor in restricted GABAergic neuronal populations in the adult rat hippocampus. J Neurosci (2010) 1.07
Cannabinoids attenuate hippocampal γ oscillations by suppressing excitatory synaptic input onto CA3 pyramidal neurons and fast spiking basket cells. J Physiol (2011) 1.07
Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress. Neurotox Res (2010) 1.05
Temporal redistribution of inhibition over neuronal subcellular domains underlies state-dependent rhythmic change of excitability in the hippocampus. Philos Trans R Soc Lond B Biol Sci (2013) 1.04
The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons. J Neurosci (2008) 1.04
Complex control of GABA(A) receptor subunit mRNA expression: variation, covariation, and genetic regulation. PLoS One (2012) 1.04
A cortico-hippocampal learning rule shapes inhibitory microcircuit activity to enhance hippocampal information flow. Neuron (2013) 1.03
NMDA receptors, mGluR5, and endocannabinoids are involved in a cascade leading to hippocampal long-term depression. Neuropsychopharmacology (2011) 1.03
Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-beta gamma dimers. Proc Natl Acad Sci U S A (2003) 1.03
Input-specific plasticity at excitatory synapses mediated by endocannabinoids in the dentate gyrus. Neuropharmacology (2007) 1.03
Control of cannabinoid CB1 receptor function on glutamate axon terminals by endogenous adenosine acting at A1 receptors. J Neurosci (2010) 1.03
A review of the interactions between alcohol and the endocannabinoid system: implications for alcohol dependence and future directions for research. Alcohol (2012) 1.02
Dysfunction of the dentate basket cell circuit in a rat model of temporal lobe epilepsy. J Neurosci (2009) 1.02
Cholinergic modulation of hippocampal network function. Front Synaptic Neurosci (2013) 1.01
Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy. Exp Neurol (2010) 1.01
Extracellular signal-regulated kinase signaling in the ventral tegmental area mediates cocaine-induced synaptic plasticity and rewarding effects. J Neurosci (2011) 1.00
Cracking down on inhibition: selective removal of GABAergic interneurons from hippocampal networks. J Neurosci (2012) 1.00
The endocannabinoid system in guarding against fear, anxiety and stress. Nat Rev Neurosci (2015) 0.99
Optogenetic release of ACh induces rhythmic bursts of perisomatic IPSCs in hippocampus. PLoS One (2011) 0.99
Addictive nicotine alters local circuit inhibition during the induction of in vivo hippocampal synaptic potentiation. J Neurosci (2010) 0.99
Cannabinoids, electrophysiology, and retrograde messengers: challenges for the next 5 years. AAPS J (2006) 0.98
AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity. PLoS One (2010) 0.98
Terminal field and firing selectivity of cholecystokinin-expressing interneurons in the hippocampal CA3 area. J Neurosci (2011) 0.98
Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. Neuropsychopharmacology (2010) 0.97
International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev (2002) 8.50
The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. Br J Pharmacol (1969) 6.01
The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev (2000) 5.40
Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A (2002) 5.33
Differences between somatic and dendritic inhibition in the hippocampus. Neuron (1996) 4.85
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience (1998) 4.39
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. Pharmacol Rev (2010) 4.31
Total number and distribution of inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells. Neuroscience (2001) 4.31
Modulation of Ca2+ channels by G-protein beta gamma subunits. Nature (1996) 3.79
GABAergic cells are the major postsynaptic targets of mossy fibers in the rat hippocampus. J Neurosci (1998) 3.63
Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Mol Pharmacol (1995) 2.95
Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci (2000) 2.69
Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol (1996) 2.55
The mechanism of acetylcholine release from parasympathetic nerves. J Physiol (1971) 2.45
Hippocampal pyramidal cells excite inhibitory neurons through a single release site. Nature (1993) 2.37
Total number and ratio of excitatory and inhibitory synapses converging onto single interneurons of different types in the CA1 area of the rat hippocampus. J Neurosci (1999) 2.27
Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci (2004) 2.25
Selective vulnerability of the hippocampus in brain ischemia. Neuroscience (1991) 2.18
Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci (2001) 2.15
Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K(+) channels that underlie the neuronal M current. J Neurosci (2000) 2.15
Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc Natl Acad Sci U S A (1993) 2.10
Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J Neurophysiol (1997) 2.05
Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines. Neuroscience (1984) 2.05
Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience (2001) 2.05
Cannabinoids inhibit emesis through CB1 receptors in the brainstem of the ferret. Gastroenterology (2001) 2.03
Stimulation, by inhibition of (Na + -K + -Mg 2+ )-activated ATP-ase, of acetylcholine release in cortical slices from rat brain. J Physiol (1972) 1.91
Interneurons containing calretinin are specialized to control other interneurons in the rat hippocampus. J Neurosci (1996) 1.91
Precision and variability in postsynaptic target selection of inhibitory cells in the hippocampal CA3 region. Eur J Neurosci (1993) 1.85
Disinhibition of rat hippocampal pyramidal cells by GABAergic afferents from the septum. J Physiol (1997) 1.82
Internalization and recycling of the CB1 cannabinoid receptor. J Neurochem (1999) 1.82
Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization. J Neurosci (1999) 1.80
The inhibitory action of noradrenaline and adrenaline on release of acetylcholine from guinea-pig ileum longitudinal strips. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 1.79
Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation. Neuroscience (1999) 1.77
Pharmacological separation of cannabinoid sensitive receptors on hippocampal excitatory and inhibitory fibers. Neuropharmacology (2002) 1.75
Input-dependent synaptic targeting of alpha(2)-subunit-containing GABA(A) receptors in synapses of hippocampal pyramidal cells of the rat. Eur J Neurosci (2001) 1.73
Synaptic input of horizontal interneurons in stratum oriens of the hippocampal CA1 subfield: structural basis of feed-back activation. Eur J Neurosci (1995) 1.72
Synaptic targets of HRP-filled layer III pyramidal cells in the cat striate cortex. Exp Brain Res (1986) 1.68
Different populations of vasoactive intestinal polypeptide-immunoreactive interneurons are specialized to control pyramidal cells or interneurons in the hippocampus. Neuroscience (1996) 1.67
Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. J Neurosci (2001) 1.63
Failed coronary stent deployment. Am Heart J (1998) 1.60
Agonist-induced internalization and trafficking of cannabinoid CB1 receptors in hippocampal neurons. J Neurosci (2001) 1.58
Effect of duration and frequency of stimulation on the presynaptic inhibition by alpha-adrenoceptor stimulation of the adrenergic transmission. Naunyn Schmiedebergs Arch Pharmacol (1973) 1.56
Compounds acting on alpha 1- and alpha 2- adrenoceptors: agonists and antagonists. Med Res Rev (1986) 1.56
Modulation of norepinephrine release by ATP-dependent K(+)-channel activators and inhibitors in guinea-pig and human isolated right atrium. Cardiovasc Res (1999) 1.56
Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice. Eur J Neurosci (2004) 1.55
Selective GABAergic innervation of thalamic nuclei from zona incerta. Eur J Neurosci (2002) 1.53
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. Eur J Neurosci (2002) 1.52
Presynaptic modulation of neurochemical transmission. Prog Neurobiol (1979) 1.52
Effect of frequency of stimulation on the inhibition by noradrenaline of the acetylcholine output from parasympathetic nerve terminals. Br J Pharmacol (1971) 1.51
Postsynaptic targets of somatostatin-immunoreactive interneurons in the rat hippocampus. Neuroscience (1999) 1.45
Postsynaptic targets of GABAergic hippocampal neurons in the medial septum-diagonal band of broca complex. J Neurosci (1993) 1.44
Calcium entry blockers increase interleukin-10 production in endotoxemia. Shock (1997) 1.43
Distinct interneuron types express m2 muscarinic receptor immunoreactivity on their dendrites or axon terminals in the hippocampus. Neuroscience (1998) 1.43
The inhibitory effect of adenosine and related nucleotides on the release of acetylcholine. Neuroscience (1976) 1.42
Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends Neurosci (2001) 1.40
Effects of vecuronium and rocuronium in antagonistic laryngeal muscles and the anterior tibial muscle in the cat. Acta Anaesthesiol Scand (2000) 1.39
Towards early defibrillation--a nurse training programme in the use of automated external defibrillators. Resuscitation (1995) 1.38
Interneurons are the local targets of hippocampal inhibitory cells which project to the medial septum. Eur J Neurosci (2003) 1.37
Bidirectional control of airway responsiveness by endogenous cannabinoids. Nature (2000) 1.36
The absence of a major Ca2+ signaling pathway in GABAergic neurons of the hippocampus. Proc Natl Acad Sci U S A (1998) 1.36
CB1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons. Neuroscience (2005) 1.35
CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents. Behav Pharmacol (2004) 1.34
The axo-axonic interneuron in the cerebral cortex of the rat, cat and monkey. Neuroscience (1982) 1.34
CB2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration. Br J Pharmacol (2007) 1.32
Innervation of cat visual areas 17 and 18 by physiologically identified X- and Y- type thalamic afferents. II. Identification of postsynaptic targets by GABA immunocytochemistry and Golgi impregnation. J Comp Neurol (1985) 1.31
An agonist of adenosine A3 receptors decreases interleukin-12 and interferon-gamma production and prevents lethality in endotoxemic mice. Eur J Pharmacol (1998) 1.29
Cell type- and synapse-specific variability in synaptic GABAA receptor occupancy. Eur J Neurosci (2000) 1.28
Calbindin D28k-containing nonpyramidal cells in the rat hippocampus: their immunoreactivity for GABA and projection to the medial septum. Neuroscience (1992) 1.27
The role of local-anesthetic effect in the inhibition of glycogenolysis in the liver of the rat. Arzneimittelforschung (1973) 1.25
Distinct properties of carbachol- and DHPG-induced network oscillations in hippocampal slices. Neuropharmacology (2004) 1.25
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience (2000) 1.25
Surviving CA1 pyramidal cells receive intact perisomatic inhibitory input in the human epileptic hippocampus. Brain (2004) 1.25
The KCl cotransporter, KCC2, is highly expressed in the vicinity of excitatory synapses in the rat hippocampus. Eur J Neurosci (2001) 1.24
ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z/P2X7 receptors. Neurochem Int (1998) 1.24
Complete axon arborization of a single CA3 pyramidal cell in the rat hippocampus, and its relationship with postsynaptic parvalbumin-containing interneurons. Eur J Neurosci (1993) 1.22
Glutamatergic synapses onto hippocampal interneurons: precision timing without lasting plasticity. Trends Neurosci (1999) 1.21
Changes in total and quantal release of acetylcholine in the mouse diaphragm during activation and inhibition of membrane ATPase. J Physiol (1979) 1.21
Altering cannabinoid signaling during development disrupts neuronal activity. Proc Natl Acad Sci U S A (2005) 1.21
Large variability in synaptic N-methyl-D-aspartate receptor density on interneurons and a comparison with pyramidal-cell spines in the rat hippocampus. Neuroscience (2003) 1.19
Subcellular localization of type 1 cannabinoid receptors in the rat basal ganglia. Neuroscience (2005) 1.18
Preservation of perisomatic inhibitory input of granule cells in the epileptic human dentate gyrus. Neuroscience (2001) 1.17
Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices. J Neurochem (1996) 1.17
Na+-K+-activated adenosinetriphosphatase as a trigger in transmitter release. Neuroscience (1978) 1.17
Localization of cannabinoid CB1 receptors in the human anterior eye and retina. Invest Ophthalmol Vis Sci (1999) 1.16
Protein kinase C disrupts cannabinoid actions by phosphorylation of the CB1 cannabinoid receptor. J Neurosci (1998) 1.14
Relationship between neuronal vulnerability and potassium-chloride cotransporter 2 immunoreactivity in hippocampus following transient forebrain ischemia. Neuroscience (2008) 1.14
Correlated morphological and neurochemical features identify different subsets of vasoactive intestinal polypeptide-immunoreactive interneurons in rat hippocampus. Neuroscience (1996) 1.13
Distribution, ultrastructure, and connectivity of calretinin-immunoreactive mossy cells of the mouse dentate gyrus. Hippocampus (1997) 1.13
Stratum radiatum giant cells: a type of principal cell in the rat hippocampus. Eur J Neurosci (1998) 1.12